Mental and behavioral disorders due to substances during the COVID-19 Pandemic: Prevalence, diagnosis, and management

Era Catur Prasetya, Kharisma Sukma Nanda, Khofifah Dwi Oktaviana, Lens Hanin Herda Zhafirah, Lia Lisa Arista, M Dedi Dermawan

Abstract

ABSTRACT

COVID-19 (Coronavirus Disease 2019) is still a significant problem; therefore, mental health issues and COVID-19 are starting to get attention because of the increasing psychological impact and mainly because of Substance Use Disorder (SUD). Further study is required on this issue. This paper aimed to determine the prevalence, diagnosis, and treatment of SUD during the COVID-19 pandemic. This literature review is gained from scientific articles with a range of publication years from 2016 to 2021 about SUD During the COVID-19 pandemic based on Prevalence, Diagnosis, and psychotherapy of the published journal using Pubmed, Google Scholar, and SAGE Journals, and then critically reviewed. The prevalence of SUD patients during the COVID-19 pandemic has increased; however, digital psychotherapy strategies for SUD patients have been found and proved effective during the pandemic. In conclusion, the COVID-19 pandemic impacts a person's mental and behavior and could be a high-risk opportunity for substance abuse. Therefore health workers must improve health services for SUD patients to receive the health access needed even in a pandemic.

Keywords: Mental Health, Substance Use Disorder, COVID-19, Prevalence, Diagnosis, Management

Correspondence : dedydermawan555@gmail.com

Keywords

Mental Health, Subtance Use Disorder, COVID-19, Prevalence, Diagnosis, Management

Full Text:

PDF

References

Alter, A., & Yeager, C. (2020). COVID-19 Impact on US National Overdose Crisis. (March), 1–5.

American Medical Association. (2020). Issue brief: Reports of Increases in opioid-related overdose during COVID pandemic. Advocacy Resource Center, (312), 1–5.

Avena, N. M., Simkus, J., Lewandowski, A., Gold, M. S., & Potenza, M. N. (2021). Substance Use Disorders and Behavioral Addictions During the COVID-19 Pandemic and COVID-19-Related Restrictions. Frontiers in Psychiatry, 12(April), 1–7. https://doi.org/10.3389/fpsyt.2021.653674

Cucinotta, D., & Vanelli, M. (2020). WHO declares COVID-19 a pandemic. Acta Biomedica, 91(1), 157–160. https://doi.org/10.23750/abm.v91i1.9397

Dietze, P. M., & Peacock, A. (2020). Illicit drug use and harms in Australia in the context of COVID-19 and associated restrictions: Anticipated consequences and initial responses. Drug and Alcohol Review, 39(4), 297–300. https://doi.org/10.1111/dar.13079

Dietze, P. M., Peacock, A., Mariottini, C., Ojanperä, I., Kriikku, P., Wang, Q. Q., … Lu, L. (2020). Mental Health, Substance Use, and Suicidal Ideation During the COVID-19. Addictive Behaviors, 29(32), 1049–1057. Retrieved from https://doi.org/10.1016/j.addbeh.2020.106754%0Ahttp://dx.doi.org/10.1038/s41380-020-00880-7

Elhai, J. D., Yang, H., Mckay, D., & Asmundson, G. J. G. (2020). COVID-19 anxiety symptoms associated with problematic smartphone use severity in Chinese adults. 274(January), 576–582.

Fabelo-Roche, J. R., Iglesias-Moré, S., & Gómez-García, A. M. (2021). Persons with substance abuse disorders and other addictions: Coping with the COVID-19 pandemic. MEDICC Review, 23(2), 55–63. https://doi.org/10.37757/MR2021.V23.N2.2

Gritsenko, V., Skugarevsky, O., Konstantinov, V., Khamenka, N., Marinova, T., Reznik, A., & Isralowitz, R. (2020). COVID 19 Fear, Stress, Anxiety, and Substance Use Among Russian and Belarusian University Students. International Journal of Mental Health and Addiction. https://doi.org/10.1007/s11469-020-00330-z

López-Pelayo, H., Aubin, H. J., Drummond, C., Dom, G., Pascual, F., Rehm, J., … Gual, A. (2020). “The post-COVID era”: Challenges in the treatment of substance use disorder (SUD) after the pandemic. BMC Medicine, 18(1), 1–8. https://doi.org/10.1186/s12916-020-01693-9

Lundahl, L. H. (2020). Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information . (January).

Marel, C., Mills, K. L., & Teesson, M. (2021). Substance use, mental disorders and COVID-19: a volatile mix. Current Opinion in Psychiatry, 34(4), 351–356. https://doi.org/10.1097/YCO.0000000000000707

Pollard, M. S., Tucker, J. S., & Green, H. D. (2020). Changes in Adult Alcohol Use and Consequences During the COVID-19 Pandemic in the US. JAMA Network Open, 3(9), e2022942. https://doi.org/10.1001/jamanetworkopen.2020.22942

Radfar, S. R., De Jong, C. A. J., Farhoudian, A., Ebrahimi, M., Rafei, P., Vahidi, M., … Zonoozi, A. K. (2021). Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey. Frontiers in Psychiatry, 12(April). https://doi.org/10.3389/fpsyt.2021.639393

Samhsa. (2021). A Preliminary Look at the Mental Health and Substance Use-related Effects of the COVID-19 Pandemic. (May).

Saunders, J. B. (2017). Substance use and addictive disorders in DSM-5 and ICD 10 and the draft ICD 11. Current Opinion in Psychiatry, 30(4), 227–237. https://doi.org/10.1097/YCO.0000000000000332

Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097. https://doi.org/10.1001/archinte.166.10.1092

Thomas McLellan, A. (2017). Substance misuse and substance use disorders: Why do they matter in healthcare? Transactions of the American Clinical and Climatological Association, 128, 112–130.

Wang, S., Zhang, Y., Ding, W., Meng, Y., Hu, H., Liu, Z., … Wang, M. (2020). Psychological distress and sleep problems when people are under interpersonal isolation during an epidemic: A nationwide multicenter cross-sectional study. European Psychiatry, 63(1). https://doi.org/10.1192/j.eurpsy.2020.78

Zhou, Q., Hu, Z., Bian, G., Yu, H., Li, X., Lu, Y., … Zhou, D. (2020). Mental health and psychosocial function of general population during the COVID‐19 epidemic in China. Clinical and Translational Medicine, 10(2), 1–5. https://doi.org/10.1002/ctm2.103


DOI: http://dx.doi.org/10.30651/jqm.v6i1.10444